临床试验市场规模、份额、按服务类型、阶段、方式、治疗领域、交付模式和地区分類的成长分析 - 2025-2032 年产业预测

2023 年临床试验市场规模价值 813 亿美元，预计将从 2024 年的 865.8 亿美元成长到 2032 年的 1,433 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.5%。

临床试验市场正在经历显着增长，原因包括新兴市场临床试验数量的增加、製药公司研发投入的活性化以及疾病（尤其是罕见疾病和孤儿病）盛行率的上升。糖尿病等疾病正在推动对创新疗法的需求，预计治疗方法年 20-79 岁人群将受其影响，而到 2045 年这一数字可能会上升至 7.837 亿。此外，欧盟委员会于 2022 年 1 月启动的「加速欧盟临床试验」等政府倡议旨在简化临床试验流程，提升欧洲作为临床研究中心的地位。这种支持性环境正在推动全球产业的发展，并促进安全有效药物的开发。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究

临床试验市场规模（按服务类型和复合年增长率） (2025-2032)

• 市场概览
• 临床试验管理与监控
• 化验服务
  • 分析测试服务
  • 生物分析测试服务
• 临床试验资料管理服务
  • 生物统计学
  • 其他资料管理服务
• 临床试验供应和物流服务
• 咨询
• 患者招募和保留
• 医学写作
• 安全和药物警戒
• 其他服务类型

临床试验市场规模（分阶段）及复合年增长率（2025-2032）

• 市场概览
• 第三阶段
• 第二阶段
• 第一阶段
• 第四阶段

临床试验市场规模（依模式划分）及复合年增长率（2025-2032）

• 市场概览
• 小分子
• 生物製药
• 医疗设备和体外诊断

临床试验市场规模（依治疗领域划分）及复合年增长率（2025-2032）

• 市场概览
• 肿瘤学
• 神经病学
• 呼吸系统疾病
• 代谢疾病/内分泌学
• 心血管疾病
• 皮肤科
• 消化系统疾病
• 免疫疾病
• 感染疾病
• 精神病学
• 眼科
• 血液学
• 泌尿生殖系统与妇女健康
• 其他治疗领域

临床试验市场规模（按交付模式和复合年增长率） (2025-2032)

• 市场概览
• 全方位服务外包（FSO）模式
• 功能服务供应商（FSP）模型
• 混合模式

临床试验市场规模（依研究设计及复合年增长率） (2025-2032)

• 市场概览
• 侵入性
• 观察性

临床试验市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 製药和生物製药公司
• 医疗设备公司
• 学术机构

各地区临床试验市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific, Inc.（US）
• IQVIA, Inc.（US）
• ICON plc（Ireland）
• Laboratory Corporation of America Holdings（US）
• Syneos Health（US）
• Charles River Laboratories（US）
• Fortrea, Inc.（US）
• SGS（Switzerland）
• ACM Global Laboratories（US）
• Advanced Clinical（US）
• PSI（Switzerland）
• BioAgile（India）
• Pepgra（India）
• CTI Clinical Trial and Consulting Services（US）
• Dove Quality Solutions（UK）
• Firma Clinical Research（US）

结论和建议

Clinical Trials Market size was valued at USD 81.3 billion in 2023 and is poised to grow from USD 86.58 billion in 2024 to USD 143.3 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The Clinical Trials Market is experiencing significant growth driven by various factors, including increased clinical trials in emerging markets, heightened R&D investment by pharmaceutical companies, and the rising prevalence of diseases, especially rare and orphan diseases. Conditions such as diabetes, which affected an estimated 536.6 million individuals aged 20 to 79 in 2021 and may rise to 783.7 million by 2045, are intensifying the demand for innovative therapies. Additionally, government initiatives, like the European Commission's Accelerating Clinical Trials in the EU program launched in January 2022, aim to streamline trial processes and enhance Europe's standing as a hub for clinical research. This supportive environment bolsters global industry growth, driving advancements in safe and effective pharmaceutical development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Market Segments Analysis

Global Clinical Trials Market is segmented by Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User and region. Based on Service Type, the market is segmented into Clinical Trial Management & Monitoring, Laboratory Services, Clinical Trial Data Management Services, Clinical Trial Supply & Logistic Services, Consulting, Patient Recruitment & Retention, Medical Writing, Safety & Pharmacovigilance and Other Service Types. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Modality, the market is segmented into Small Molecules, Biologics and Medical Devices & IVD. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Respiratory Disorders, Metabolic Disorders/Endocrinology, Cardiovascular System Disorders, Dermatology, Gastrointestinal Diseases, Immunological Disorders, Infectious Diseases, Psychiatry, Ophthalmology, Hematology, Genitourinary & Women's Health and Other Therapeutic Areas. Based on Delivery Model, the market is segmented into Full-Service Outsourcing (FSO) Model, Functional Service Provider (FSP) Model and Hybrid Model. Based on Study Design, the market is segmented into Interventional and Observational. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Market

The growth of the Clinical Trials market is significantly propelled by increased investments in research and development by biotechnology and pharmaceutical companies. To successfully develop and launch new therapies, these organizations must meticulously design clinical trials. A surge in both public and private funding enables them to implement larger-scale research projects that enhance the safety and efficacy evaluations of new drugs. Such financial backing expedites the medication approval process and ultimately improves patient access to innovative treatments. Additionally, this investment fosters the discovery of new therapies while elevating the standards of clinical research, thus driving overall market growth.

Restraints in the Clinical Trials Market

Regulatory challenges significantly hinder the clinical trials market, often causing substantial delays in research and development due to difficulties in obtaining necessary approvals. Regulatory bodies like the FDA and EMA impose stringent requirements that necessitate meticulous documentation and adherence to Good Clinical Practice (GCP), along with comprehensive safety measures. These stringent regulations can be particularly burdensome for smaller firms, which may be deterred from initiating clinical studies due to the high costs associated with regulatory compliance. Additionally, varying national regulations in multi-national trials complicate the process further, slowing progress and limiting access to a diverse range of patient populations.

Market Trends of the Clinical Trials Market

The clinical trials market is witnessing a significant shift towards decentralized clinical trials (DCTs), driven by advancements in technology that enable virtual participation and remote patient monitoring. This trend enhances accessibility and flexibility for participants, ultimately fostering higher engagement through the use of wearable devices, telemedicine, and mobile health applications. As DCTs reduce travel-related costs and streamline data collection, they facilitate more efficient patient recruitment and retention, thereby expediting the overall clinical trial process. This evolution not only promises improved patient experiences but also holds the potential to transform the landscape of clinical research, making it more adaptive to modern healthcare needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Clinical Trials Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Clinical Trial Management & Monitoring
• Laboratory Services
  • Analytical Testing Services
  • Bioanalytical Testing Services
• Clinical Trial Data Management Services
  • Biostatistics
  • Other Data Management Services
• Clinical Trial Supply & Logistic Services
• Consulting
• Patient Recruitment & Retention
• Medical Writing
• Safety & Pharmacovigilance
• Other Service Types

Global Clinical Trials Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase III
• Phase II
• Phase I
• Phase IV

Global Clinical Trials Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics
• Medical Devices & IVD

Global Clinical Trials Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Respiratory Disorders
• Metabolic Disorders/Endocrinology
• Cardiovascular System Disorders
• Dermatology
• Gastrointestinal Diseases
• Immunological Disorders
• Infectious Diseases
• Psychiatry
• Ophthalmology
• Hematology
• Genitourinary & Women's Health
• Other Therapeutic Areas

Global Clinical Trials Market Size by Delivery Model & CAGR (2025-2032)

• Market Overview
• Full-Service Outsourcing (FSO) Model
• Functional Service Provider (FSP) Model
• Hybrid Model

Global Clinical Trials Market Size by Study Design & CAGR (2025-2032)

• Market Overview
• Interventional
• Observational

Global Clinical Trials Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Global Clinical Trials Market Size & CAGR (2025-2032)

• North America (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
  • US
  • Canada
• Europe (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Phase, Modality, Therapeutic Area, Delivery Model, Study Design, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dove Quality Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Firma Clinical Research (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations